HBV
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
The aMAP Score Effectively Stratifies Hepatocellular Carcinoma Risk in the Steatotic Liver Disease Population.
Xu Wenxin (W);Shi Yaru (Y);Liu Zhihong (Z);Ma Hong (H);Niu Junqi (J);Xie Qing (Q);Xie Jianping (J);Rao Huiying (H);Yang Song (S);Zhong Chunxiu (C);Dou Xiaoguang (X);Xie Dongying (D);Yin Junhua (J);Sun Aimin (A);Yang Yongfeng (Y);Liu Yali (Y);Xu Ya (Y);Li Qiang (Q);Jiang Yongfang (Y);Li Wu (W);Tang Hong (H);Lian Jianqi (J);Lin Huapeng (H);Sun Jian (J);Hou Jinlin (J);Fan Rong (R); ()
Similar Long-Term Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Initiating Entecavir Versus Tenofovir Alafenamide: A REAL-B Study.
Uojima Haruki (H);Huang Rui (R);Trinh Huy (H);Nozaki Akito (A);Vutien Philip (P);Toyoda Hidenori (H);Honda Takashi (T);Abe Hiroshi (H);Atsukawa Masanori (M);Watanabe Tsunamasa (T);Ishikawa Toru (T);Enomoto Masaru (M);Tanaka Yasuhito (Y);Takaguchi Koichi (K);Tsai Pei-Chien (PC);Chuang Wan-Long (WL);Dai Chia-Yen (CY);Huang Jee-Fu (JF);Huang Chung-Feng (CF);Yeh Ming-Lun (ML);Senoh Tomonori (T);Maeda Mayumi (M);Cheung Ramsey (R);Ito Takanori (T);Morimoto Manabu (M);Yu Ming-Lung (ML);Wu Chao (C);Nguyen Mindie H (MH)
Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of 78 Studies and 68,243 Patients.
Kudaravalli Sahith (S);Yan Taotao (T);Tseng Cheng-Hao (CH);Hsu Yao-Chun (YC);Li Xiaohe (X);Wu Yuankai (Y);Chen Bowu (B);Gao Xiangrong (X);Gao Sicheng (S);Ren Danfeng (D);Qian Xiaohan (X);Sands Warren (W);Cheung Ramsey (R);Nguyen Mindie H (MH)
Safety, Tolerability and Antiviral Activity of GST-HG131 in Chronic Hepatitis B: A Randomized, Double-Blind Phase IIa Study.
Guo Yuming (Y);Xu Zhe (Z);Li Yuanyuan (Y);Mao John (J);Zhang Tianxiang (T);Li Yonggang (Y);Meng Fanping (F);Fu Junliang (J);Ji Dong (D);Ji Yingjie (Y);Cheng Yongqian (Y);Zhang Min (M);Zhang Xin (X);Sun Ying (Y);Huang Zuxiong (Z);Cai Dachuan (D);Wu Wenqiang (W);Yan Wenhao (W);Yan Xiuping (X);Li Guoping (G);Hou Jinlin (J);Zhang George (G);Wang Fu-Sheng (FS)
Finite Versus Indefinite Nucleos(t)ide Analogue Therapy in HBeAg‑Negative Chronic Hepatitis B: Meta‑Analysis of Randomized Trials.
Gomez Demver P (DP);Hababag Wilmyr F (WF)
Becoming Physically Active and Risks of Mortality and Liver-Related Events in Adults With Chronic Hepatitis B: A Nationwide Cohort Study.
Song Byeong Geun (BG);Lee Myeongcheol (M);Cho Juhee (J);Gwak Geum-Youn (GY);Kang Danbee (D);Sinn Dong Hyun (DH)
Therapeutic advances in chronic hepatitis B and Delta: where are we now and where are we headed?
Pocurull Anna (A);Battistella Sara (S);Forns Xavier (X);Lens Sabela (S)
Safety and Effectiveness of Dolutegravir/Rilpivirine in Japanese People Living with HIV: Final Report of 6-Year Post-marketing Surveillance Study.
Sebata Akemi (A);Nagao Takako (T);Matsukawa Tomoko (T);Yoshikawa Yoichiro (Y);Fukuda Akiko (A);Wang Dong (D)
Selection and Management of Patients With Resectable Gastric or Gastroesophageal Junction Cancer Receiving Perioperative FLOT: A Modified Delphi Consensus Approach.
Saeed Anwaar (A);Janjigian Yelena Y (YY);Gibson Michael K (MK);DeRemer David L (DL);Ko Andrew H (AH);Fontana Toni (T);Smyth Elizabeth C (EC);Shaib Walid L (WL);Oh Do-Youn (DY);Chen Ming-Huang (MH);Klempner Samuel J (SJ);Molena Daniela (D);Shelby Emily (E);Strong Vivian E (VE);Al-Batran Salah-Eddin (SE);Shitara Kohei (K)
Projected Effect of 2026 Federal Changes to the Childhood Immunization Schedule on Chronic Hepatitis B Virus Infections in the United States.
Mohareb Amir M (AM);Ganapathi Lakshmi (L);Dugdale Caitlin M (CM);Rajbhandari Ruma (R);Ciaranello Andrea (A);Neilan Anne M (AM);Jhaveri Ravi (R);Kim Arthur Y (AY);Hyle Emily P (EP)
Hepatic Cysts in Korea: Prevalence, Incidence, and Risk Factors Based on a 5.8-Year Follow-up Health Screening Cohort.
Seo Kang (K);Kim Yujeong (Y);Park Sang Hyuk (SH);Yi Nam-Joon (NJ);Yoon Jeong Hee (JH);Chung Goh Eun (GE);Lee Jeong-Moo (JM);Rho Seoung Yoon (SY);Park Min Su (MS);Choe Eun Kyung (EK);Shin Aesun (A)
Distinct immune signatures define hepatitis D- versus hepatitis B-associated hepatocellular carcinoma.
Glimmann Simon (S);Deterding Katja (K);Bock Kilian (K);Bremer Birgit (B);Kraft Anke R M (ARM);Cornberg Markus (M);Wedemeyer Heiner (H);Heinrich Bernd (B);Wranke Anika (A)
Retrospective observational study of transcatheter arterial chemoembolization (TACE) combined with PD-1 inhibitor and tyrosine kinase inhibitor (TKI) in advanced hepatocellular carcinoma.
Xu Guohui (G);Zhang Jianlong (J);Li Xiaojun (X);Fan Shilan (S);Wu Xiao (X);Zhou Cuncai (C)
Histopathologic spectrum of focal liver lesions diagnosed by ultrasound-guided percutaneous liver biopsy and predictors of hepatocellular carcinoma: A single-center experience from Sub-Saharan Africa.
Elias Tamrat Petros (TP);Shewaye Abate Bane (AB);Berhane Kaleb Assefa (KA);Mohammed Abdu (A);Tibebu Zebeaman (Z);Gebreselassie Amanuel Getu (AG);Abie Abraham Sisay (AS)
Evaluating the potential of treatment options for chronic hepatitis B.
Huang Shang-Chin (SC);Kao Jia-Horng (JH)
A comprehensive evaluation on the impact of MASLD on the prognosis of chronic hepatitis B-related hepatocellular carcinoma following hepatectomy: results from retrospective multicenter cohort study and meta-analysis.
Chen Yiyu (Y);Ou Yangyang (Y);Chen Kang (K);Liang Tianyi (T);Su Jiayong (J);Ye Xinping (X);Ma Liang (L);Yao Ming (M);Guo Junjiang (J);Liang Liang (L);Li Jianjun (J);Nong Yuanneng (Y);Chen Ji An (JA);Huang Fei (F);Peng Tao (T);Zhong Jian-Hong (JH);Yan Yihe (Y)
Harm reduction services in female prisons: a scoping review exploring the situation in the MENA region.
Salameh Isabelle (I);Aaraj Elie (E)
Multifactorial Contributors to Diagnostic Delay in a High-Risk Patient with Hepatocellular Carcinoma: A Case Report with Clinical Lessons.
Hu Jiao (J);Guo Liping (L);Chen Tongen (T);Zhang Jingfeng (J);Jiang Qiaoqiao (Q)